188 related articles for article (PubMed ID: 19240070)
21. Occurrence and detection of AmpC beta lactamases among clinical isolates of E. coli and K. pneumoniae causing UTI.
Rajni E; Rawat U; Malhotra VL; Mehta G
J Commun Dis; 2008 Mar; 40(1):21-5. PubMed ID: 19127665
[TBL] [Abstract][Full Text] [Related]
22. Plasmid-encoded OXA-48 carbapenemase in Escherichia coli from Israel.
Goren MG; Chmelnitsky I; Carmeli Y; Navon-Venezia S
J Antimicrob Chemother; 2011 Mar; 66(3):672-3. PubMed ID: 21177669
[No Abstract] [Full Text] [Related]
23. Molecular characterization of plasmids encoding CTX-M-15 extended-spectrum beta-lactamase associated with the ST131 Escherichia coli clone in Belgium.
Montesinos I; Rodriguez-Villalobos H; De Mendonça R; Bogaerts P; Deplano A; Glupczynski Y
J Antimicrob Chemother; 2010 Aug; 65(8):1828-30. PubMed ID: 20534625
[No Abstract] [Full Text] [Related]
24. Escherichia coli of animal origin in Norway contains a blaTEM-20-carrying plasmid closely related to blaTEM-20 and blaTEM-52 plasmids from other European countries.
Sunde M; Tharaldsen H; Slettemeås JS; Norström M; Carattoli A; Bjorland J
J Antimicrob Chemother; 2009 Jan; 63(1):215-6. PubMed ID: 18971216
[No Abstract] [Full Text] [Related]
25. Extended-spectrum {beta}-lactamases and AmpC {beta}-lactamases in ceftiofur-resistant Salmonella enterica isolates from food and livestock obtained in Germany during 2003-07.
Rodríguez I; Barownick W; Helmuth R; Mendoza MC; Rodicio MR; Schroeter A; Guerra B
J Antimicrob Chemother; 2009 Aug; 64(2):301-9. PubMed ID: 19474065
[TBL] [Abstract][Full Text] [Related]
26. Analysis of plasmid-mediated multidrug resistance in Escherichia coli and Klebsiella oxytoca isolates from clinical specimens in Japan.
Ode T; Saito R; Kumita W; Sato K; Okugawa S; Moriya K; Koike K; Okamura N
Int J Antimicrob Agents; 2009 Oct; 34(4):347-50. PubMed ID: 19560903
[TBL] [Abstract][Full Text] [Related]
27. Escherichia coli producing VIM-1 carbapenemase isolated on a pig farm.
Fischer J; Rodríguez I; Schmoger S; Friese A; Roesler U; Helmuth R; Guerra B
J Antimicrob Chemother; 2012 Jul; 67(7):1793-5. PubMed ID: 22454489
[No Abstract] [Full Text] [Related]
28. First case of New Delhi metallo-beta-lactamase 1-producing Escherichia coli infection in Japan.
Chihara S; Okuzumi K; Yamamoto Y; Oikawa S; Hishinuma A
Clin Infect Dis; 2011 Jan; 52(1):153-4. PubMed ID: 21148536
[No Abstract] [Full Text] [Related]
29. Analysis of the beta-lactam resistance phenotypes of Escherichia coli. An 8-year survey conducted in Greece.
Neonakis IK; Baritaki S; Georgiladakis A; Spandidos DA
Roum Arch Microbiol Immunol; 2008; 67(1-2):10-3. PubMed ID: 19284160
[TBL] [Abstract][Full Text] [Related]
30. Molecular epidemiology of Escherichia coli producing extended-spectrum {beta}-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15.
Blanco M; Alonso MP; Nicolas-Chanoine MH; Dahbi G; Mora A; Blanco JE; López C; Cortés P; Llagostera M; Leflon-Guibout V; Puentes B; Mamani R; Herrera A; Coira MA; García-Garrote F; Pita JM; Blanco J
J Antimicrob Chemother; 2009 Jun; 63(6):1135-41. PubMed ID: 19351692
[TBL] [Abstract][Full Text] [Related]
31. Bacteraemia with extended-spectrum beta-lactamases-producing Escherichia coli in Hong Kong.
You JH; Mok SS; Chang CC; Lee N; Ip M
Int J Antimicrob Agents; 2009 Dec; 34(6):615-6. PubMed ID: 19744835
[No Abstract] [Full Text] [Related]
32. In vivo selection of an Escherichia coli isolate highly resistant to ciprofloxacin and ceftazidime: role of a 4-bp duplication in acrR and ampC overexpression.
Corvec S; Lepelletier D; Reynaud A; Dauvergne S; Giraudeau C; Caroff N
Int J Antimicrob Agents; 2008 Aug; 32(2):196-8. PubMed ID: 18571906
[No Abstract] [Full Text] [Related]
33. CTX-M-type beta-lactamases affect community Escherichia coli treatment, Greece.
Pournaras S; Ikonomidis A; Sofianou D; Tsakris A; Maniatis AN
Emerg Infect Dis; 2004 Jun; 10(6):1163-4. PubMed ID: 15224673
[No Abstract] [Full Text] [Related]
34. Extended-spectrum and AmpC beta-lactamases in Escherichia coli and Klebsiella pneumoniae from a rural South Indian tertiary care hospital.
Navaneeth BV
Int J Antimicrob Agents; 2007 May; 29(5):602-3. PubMed ID: 17296286
[No Abstract] [Full Text] [Related]
35. Hyperproduction of AmpC beta-lactamase in a clinical isolate of Escherichia coli associated with a 30 bp deletion in the attenuator region of ampC.
Fernández-Cuenca F; Pascual A; Martínez-Martínez L
J Antimicrob Chemother; 2005 Jul; 56(1):251-2. PubMed ID: 15890720
[No Abstract] [Full Text] [Related]
36. Emergence of extended-spectrum beta-lactamases in clinical isolates of Salmonella enterica in Tehran, Iran.
Hamidian M; Tajbakhsh M; Walther-Rasmussen J; Zali MR
Jpn J Infect Dis; 2009 Sep; 62(5):368-71. PubMed ID: 19762986
[TBL] [Abstract][Full Text] [Related]
37. Escherichia coli from community-acquired urinary tract infections resistant to fluoroquinolones and extended-spectrum beta-lactams.
Kariuki S; Revathi G; Corkill J; Kiiru J; Mwituria J; Mirza N; Hart CA
J Infect Dev Ctries; 2007 Dec; 1(3):257-62. PubMed ID: 19734602
[TBL] [Abstract][Full Text] [Related]
38. Molecular characterization of CTX-M-15-producing clinical isolates of Escherichia coli reveals the spread of multidrug-resistant ST131 (O25:H4) and ST964 (O102:H6) strains in Norway.
Naseer U; Haldorsen B; Tofteland S; Hegstad K; Scheutz F; Simonsen GS; Sundsfjord A;
APMIS; 2009 Jul; 117(7):526-36. PubMed ID: 19594493
[TBL] [Abstract][Full Text] [Related]
39. [Extended-spectrum beta-lactamases in isolates of Escherichia coli and Klebsiella sp. from inanimate reservoir at a hospital in northern Peru].
Rivera-Jacinto MA
Rev Esp Quimioter; 2012 Jun; 25(2):161-3. PubMed ID: 22707106
[No Abstract] [Full Text] [Related]
40. Occurrence of extended-spectrum (beta)-lactamases and plasmid-mediated AmpC (beta)-lactamases among Korean isolates of Proteus mirabilis.
Park YJ; Lee S; Kim YR; Oh EJ; Woo GJ; Lee K
J Antimicrob Chemother; 2006 Jan; 57(1):156-8. PubMed ID: 16284101
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
